TIDALSENSE LIMITED
Company number 08500211 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
TIDALSENSE LIMITED – Financial Health Assessment
Financial Health Score: D (Poor)
The company is in a pre-revenue or very early revenue phase with significant accumulated losses, negative working capital, and negative equity. While it has a credible investor base and sufficient cash to continue operations in the near term, the underlying financial condition shows clear symptoms of distress. Without a clear path to revenue growth and cost control, the prognosis remains guarded.
Key Vital Signs
| Metric | 2024 | 2023 | Healthy Range | Interpretation |
|---|---|---|---|---|
| Current Ratio | 0.77 | 4.63 | >1.5 | Critical – Current liabilities exceed current assets; short-term liquidity pressure. |
| Quick Ratio | 0.75 | 4.59 | >1.0 | Critical – Even excluding stock, the company cannot cover immediate debts. |
| Cash Ratio | 0.41 | 3.08 | >0.5 | Warning – Cash covers only 41% of short-term liabilities. |
| Net Current Assets | (£531,960) | £1,777,731 | Positive | Critical – Working capital deficit of over half a million pounds. |
| Net Assets / Equity | (£230,567) | £1,933,230 | Positive | Critical – Negative equity means liabilities exceed assets; technically insolvent on a balance sheet basis. |
| Accumulated Losses (P&L Reserve) | (£9,255,006) | (£6,405,344) | Positive | Critical – Losses have grown by £2.85m in one year, indicating high cash burn. |
| Cash & Equivalents | £925,651 | £1,510,399 | Sufficient for 6-12 months | Warning – Cash has dropped £585k despite raising £686k equity and £1.58m in convertible loans. Implies heavy operating cash outflow. |
| Debt Burden (Current Liabilities) | £2,280,772 | £489,941 | Manageable | Critical – Liabilities nearly quadrupled, driven by £1.58m convertible loans. |
| Revenue Indicator (Trade Debtors) | £50,890 | £52,407 | Growing | Flat – Minimal revenue generation; company still in R&D/commercialisation stage. |
| Shareholders’ Funds / Total Assets | -11% | 80% | >50% | Critical – Negative equity ratio; assets are funded by debt and negative reserves. |
Diagnosis
Primary Condition: Acute Financial Distress with Chronic Loss-Making
TidalSense is exhibiting classic symptoms of a high-burn, pre-revenue technology company that has not yet achieved commercial viability. The financial data reveals three interconnected issues:
-
Negative Working Capital – The company owes more in the next 12 months (£2.28m) than it holds in current assets (£1.75m). This is like having a heart that cannot pump enough blood to vital organs. The £1.58m convertible loan (now due within one year) is the primary pressure point.
-
Negative Equity – Total liabilities exceed total assets by £230,567. This is a technical insolvency position. The company is effectively "living on borrowed time and investor goodwill." The accumulated losses of £9.26m far exceed the share capital and premium raised to date.
-
Unsustainable Cash Burn – Despite raising £686k in new equity and £1.58m in convertible loans during 2024, cash fell by £585k. The underlying operating cash outflow is estimated at £2.67m for the year – a burn rate of approximately £220k per month. At the current cash level (£926k), the company has only 4-5 months of runway without additional funding.
Secondary Symptoms
- Low Revenue – Trade debtors of £51k suggest turnover is negligible relative to costs. The company remains in the "research and experimental development" phase (SIC 72190).
- Dependence on External Funding – The company has raised over £9m in share premium and £1.58m in convertible loans. This is a lifeline, but it creates dilution and debt service risk.
- Investor Support – The presence of BGF Investment Management and Gas Sensing Solutions as significant shareholders provides some comfort, but these investors will expect a return path.
Positive Signs (Vital but Insufficient)
- The company is investing in fixed assets (£145k additions in 2024) – a sign of product development progress.
- The directors have stated a going concern basis, implying they believe further funding is achievable.
- The company has a clear business purpose (AI-driven respiratory diagnostics) and a professional board with multiple directors.
Prognosis
Immediate Outlook (Next 6-12 Months): Guarded
Without an immediate injection of new funding (equity, grants, or revenue), the company faces a high risk of running out of cash within 5 months. The convertible loans may need to be renegotiated, converted, or refinanced. If the company cannot demonstrate progress toward commercialisation, investors may withdraw support.
Medium-Term Outlook (1-3 Years): Uncertain
The prognosis depends entirely on: - Revenue generation – Can TidalSense convert its R&D into sales? Even modest revenue would improve the picture. - Cost control – The current burn rate is unsustainable. A "cash diet" is essential. - Funding success – Another significant funding round (likely £3-5m) will be needed to reach profitability.
If the company secures a major contract or regulatory approval, it could turn around. If not, insolvency or a distressed sale becomes a real possibility.
Recommendations (Prescription for Recovery)
1. Emergency Cash Management (Immediate)
- Extend runway: Reduce discretionary spending, freeze non-essential hires, and renegotiate supplier terms.
- Convertible loan strategy: Work with lenders to extend maturity or convert debt to equity to relieve short-term pressure.
2. Revenue Acceleration (Short-Term)
- Commercialise existing products: Focus on early sales to generate even modest cash inflows.
- Pursue grant funding: The company's R&D nature makes it eligible for Innovate UK, NIHR, or Horizon Europe grants.
3. Balance Sheet Restructuring (6-12 Months)
- Equity injection: A new funding round should aim to eliminate negative equity and provide 18-24 months of runway.
- Debt-to-equity conversion: Convert the £1.58m convertible loan to strengthen the balance sheet.
4. Operational Efficiency (Ongoing)
- Monitor cash burn weekly: Implement a 13-week cash flow forecast.
- Review headcount: 20 employees is significant for a company with minimal revenue. Assess productivity and alignment with commercial milestones.
5. Transparent Communication
- Update investors regularly on progress toward revenue and funding milestones.
- File accounts on time to maintain stakeholder confidence.